Shigella ubiquitin ligase IpaH7.8 targets gasdermin D for degradation to prevent pyroptosis and enable infection
Authors:
Top Cited Papers
Open Access
- 6 September 2021
- journal article
- research article
- Published by Elsevier in Cell Host & Microbe
- Vol. 29 (10) , 1521-1530.e10
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AI075039)
- National Institutes of Health (AI155634)
- National Institutes of Health (AI063302)
- Genentech
- Howard Hughes Medical Institute
This publication has 59 references indexed in Scilit:
- Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificityNature, 2011
- Listeria monocytogenes engineered to activate the Nlrc4 inflammasome are severely attenuated and are poor inducers of protective immunityProceedings of the National Academy of Sciences, 2011
- Generation of a Listeria vaccine strain by enhanced caspase‐1 activationEuropean Journal of Immunology, 2011
- Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteriaNature Immunology, 2010
- Fast and SNP-tolerant detection of complex variants and splicing in short readsBioinformatics, 2010
- Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In SituMolecular Cell, 2010
- BLAST+: architecture and applicationsBMC Bioinformatics, 2009
- Shigella type III secretion effectors: how, where, when, for what purposes?Current Opinion in Microbiology, 2009
- Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTipsNature Protocols, 2007
- Type III Secretion Effectors of the IpaH Family Are E3 Ubiquitin LigasesCell Host & Microbe, 2007